ASX-Dividend-Report-Banner

Healthcare


 Will Clarity Pharmaceuticals' Imaging Agent Change Prostate Cancer Detection?

Will Clarity Pharmaceuticals' Imaging Agent Change Prostate Cancer D...

February 19, 2025 01:31 PM AEDT | By Team Kalkine Media

Highlights,FDA fast-track designation for prostate cancer imaging agent.,Innovation in dual-targeted bisPSMA technology developed in Australian labora...

 Why Cyclopharm's (ASX:CYC) Cash Burn Isn't a Major Concern for Us

Why Cyclopharm's (ASX:CYC) Cash Burn Isn't a Major Concern for Us

February 19, 2025 11:32 AM AEDT | By Team Kalkine Media

Highlights,Cyclopharm's cash reserves suggest a stable runway for growth.,Analyst forecasts indicate potential for cashflow breakeven soon.,Market cap...

 How Are ASX-Listed Healthcare Companies Advancing Cancer Diagnostics and Treatments?

How Are ASX-Listed Healthcare Companies Advancing Cancer Diagnostics...

February 19, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights:,Imagion Biosystems is leading the charge in cancer diagnostics with its MagSense platform for HER2+ breast cancer.,Noxopharm focuses on in...

 Biocurious: As Mayne Pharmaceuticals faces a takeover bid, who might be next?

Biocurious: As Mayne Pharmaceuticals faces a takeover bid, who might...

February 19, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights:,Acquisition Momentum:,The agreement for Mayne Pharma to be acquired by Cosette has brought attention to the broader ASX biotech space, hig...

 Little Green Pharma Ltd (ASX:LGP) Recovery and Strategic Valuation in the Pharmaceuticals Sector

Little Green Pharma Ltd (ASX:LGP) Recovery and Strategic Valuation i...

February 18, 2025 01:33 PM AEDT | By Team Kalkine Media

Little Green Pharma Ltd (ASX:LGP) Recovery and Strategic Valuation in the Pharmaceuticals Sector

 HMC Capital Considers Healthscope Acquisition with Focus on Workforce Stability

HMC Capital Considers Healthscope Acquisition with Focus on Workforc...

February 18, 2025 12:04 PM AEDT | By Team Kalkine Media

Highlights:,HMC Capital explores a potential acquisition of Healthscope, aiming to,maintain,operational stability.,The company,seeks,to minimise facil...

 Health Check: It's Time to Showcase Our Three Local Heroes

Health Check: It's Time to Showcase Our Three Local Heroes

February 18, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights:,Nanosonics prepares to introduce Coris, a new anti-infection device designed for hospital instrument cleaning.,Cogstate experiences revenu...

 Health Check: Brokers Reduce Cochlear Valuations as Customers Delay Product Upgrades

Health Check: Brokers Reduce Cochlear Valuations as Customers Delay...

February 18, 2025 11:00 AM AEDT | By Team Kalkine Media

Biotech Industry Update: Key Developments and Trials

 Recce Pharmaceuticals Advances in Fight Against Skin Infections with Promising Phase II Trial Results

Recce Pharmaceuticals Advances in Fight Against Skin Infections with...

February 17, 2025 10:18 PM AEDT | By Team Kalkine Media

Highlights:,Positive results from Phase II trial of Recce 327 topical gel,No serious adverse events reported, meeting all safety and efficacy endpoint...

 ASX Closes Lower as (ASX:AD8) Surges 26% and (ASX:BEN) Faces Sharp Decline

ASX Closes Lower as (ASX:AD8) Surges 26% and (ASX:BEN) Faces Sharp D...

February 17, 2025 06:11 PM AEDT | By Team Kalkine Media

Highlights,(ASX:AD8) jumps 26% after strong half-year results,(,ASX:BEN,) slides 15% on weaker margins and earnings shortfall,Seven sectors end in the...

 Sonic Healthcare (ASX:SHL): A Closer Look at Stock Performance and Long-Term Outlook

Sonic Healthcare (ASX:SHL): A Closer Look at Stock Performance and L...

February 17, 2025 04:17 PM AEDT | By Team Kalkine Media

Highlights,Sonic Healthcare (SHL) sees a 10% rise in,quarterly,share price.,Shareholder,return over the past three years shows a 23% decline.,Dividend...

 Recce Pharmaceuticals Shows Promising Results for Topical Gel in Treating Skin Infections, Sets Stage for Phase 3 Study

Recce Pharmaceuticals Shows Promising Results for Topical Gel in Tre...

February 17, 2025 03:20 PM AEDT | By Team Kalkine Media

Highlights,Recce Pharmaceuticals’ Phase II clinical trial of its topical gel, RECCE 327 (R327G), achieved a 93% primary efficacy endpoint in treating...

 Recce Pharmaceuticals (ASX:RCE) Advances R327G to Phase III After Positive Phase II Trial Results

Recce Pharmaceuticals (ASX:RCE) Advances R327G to Phase III After Po...

February 17, 2025 01:12 PM AEDT | By Team Kalkine Media

Highlights:,93% Efficacy Rate:,Recce Pharmaceuticals (ASX:RCE) reported that R327G achieved a 93% primary efficacy endpoint in its Phase II trial for...

 Althea Group’s Expansion into the North American THC Beverage Market

Althea Group’s Expansion into the North American THC Beverage Market

February 17, 2025 12:30 PM AEDT | By Team Kalkine Media

Cannabis in a Can: Nanocap Althea Secures $4M to Boost THC Beverage Expansion in the US and Canada

 Recce Pharmaceuticals (ASX:RCE) Advances ABSSSI Treatment with Positive Phase II Trial Results

Recce Pharmaceuticals (ASX:RCE) Advances ABSSSI Treatment with Posit...

February 17, 2025 11:30 AM AEDT | By Team Kalkine Media

Breakthrough in Infection Treatment: Recce Pharmaceuticals (ASX:RCE) Reports Strong Clinical Results

 Health Check: After treating its final patient, Opthea anticipates the crucial outcomes of its make-or-break trial.

Health Check: After treating its final patient, Opthea anticipates t...

February 17, 2025 11:00 AM AEDT | By Team Kalkine Media

Biotech Developments and Market Movements in Focus

 Imugene is well-funded and on the brink of revolutionizing cancer immunotherapy.

Imugene is well-funded and on the brink of revolutionizing cancer im...

February 17, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights:,Imugene is advancing three immunotherapy programs focused on CAR-T therapies and oncolytic viruses.,The company secured new funding throug...

 Will ASX:ARX Reinvent Its Course in a Rapidly Expanding Sector?

Will ASX:ARX Reinvent Its Course in a Rapidly Expanding Sector?

February 16, 2025 11:30 AM AEDT | By Team Kalkine Media

Highlights,ASX:ARX experienced a sharp decline in share price, erasing earlier gains.,The company’s price-to-sales ratio remains much lower compared t...

 CSL's Earnings for the First Half of 2025: EPS Falls Short of Expectations

CSL's Earnings for the First Half of 2025: EPS Falls Short of Expect...

February 16, 2025 11:30 AM AEDT | By Team Kalkine Media

Highlights:,CSL Limited (ASX:CSL) reported an increase in revenue in its latest financial results.,Earnings per share came in below expectations despi...

 Can Imagion Biosystems Transform HER2 Imaging for Cancer Diagnostics?

Can Imagion Biosystems Transform HER2 Imaging for Cancer Diagnostics...

February 16, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights,• MagSense HER2 imaging agent manufacturing commences for advanced clinical trials.,• Innovative imaging technology aims to enhance cancer...

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.